NCT02847325View on ClinicalTrials.gov

Study of AC0058TA in Healthy Male and Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Healthy Volunteers
Interventions
DRUG

AC0058TA

50 mg AC0058TA 100 mg AC0058TA 200 mg AC0058TA 400 mg AC0058TA

DRUG

Placebo capsules

Placebo capsules

Trial Locations (1)

75247

Covance Clinical Development Services, Dallas

Sponsors
All Listed Sponsors
lead

ACEA Therapeutics, Inc.

INDUSTRY